Shalini Bhardwaj New Delhi [India], July 2 (ANI): A decision on the approval of Zydus Cadila’s COVID-19 vaccine Zydus Cov-D is coming soon, said Dr. VK Paul, a member of NITI Aayog (health), on Friday, with data and ratings. Determine the result.
“The Drugs Controller General of India (DCGI) is applying for Zydus Cadila, which is in the process of being evaluated by the Subject Expert Committee. We hope to hear a swift and positive decision,” Paul said. The doctor told ANI.
Ahmedabad-based pharmaceutical company has requested urgent approval for ZyCoV-D, a triple-dose Covid shot of the world’s first plasmid DNA vaccine.
“It will be a moment of pride because it is a unique technology. It will boost the national vaccination program,” said Dr. Paul.
ZyCoV-D is an intradermal vaccine applied using PharmaJet’s needleless system Tropis. This can also significantly reduce all kinds of side effects.
Zydus also claims to be 66.6% effective for symptomatological Covid cases and 100% effective for moderate illness. After the second vaccination, there were no serious cases or deaths due to COVID-19 in the vaccine group.
According to a recent statement from a pharmaceutical company, “approved vaccines are useful not only for adults, but also for adolescents aged 12-18.” The company plans to produce 1 to 1.2 billion rupees a year and 500 million rupees a month. In December. (ANI)
Nodding decision for Zydus Cov-D vaccine is expected soon
Source link Nodding decision for Zydus Cov-D vaccine is expected soon